Allogeneic bone marrow transplantation for chronic myeloid leukemia

Bone Marrow Transplantation

Volumn 17, Issue SUPPL. 3, 1996, Pages

  Gratwohl, A ^a   Hermans, J ^b  

^a UNIVERSITY HOSPITAL BASEL   (Switzerland)

^b NONE

Author keywords

Bone marrow transplantation; Chronic myeloid leukemia; Risk factors survival

Indexed keywords

ALLOGENIC BONE MARROW TRANSPLANTATION; BLAST CELL CRISIS; CANCER SURVIVAL; CHRONIC MYELOID LEUKEMIA; CONDITIONING; CONFERENCE PAPER; DONOR; GRAFT VERSUS HOST REACTION; HUMAN; MAJOR CLINICAL STUDY; MORTALITY; PRIORITY JOURNAL; RELAPSE; RISK FACTOR; SIBLING; TREATMENT OUTCOME;

ACUTE DISEASE; BONE MARROW TRANSPLANTATION; EUROPE; GRAFT VS HOST DISEASE; HUMANS; LEUKEMIA, MYELOID, CHRONIC; RECURRENCE; RISK FACTORS; TISSUE DONORS; TRANSPLANTATION, HOMOLOGOUS;

EID: 0029939567     PISSN: 02683369     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (14)

1. Fefer A, Cheever MA, Thomas ED. Disappearance of ph-pos cells in four patients with chronic myelogenous leukemia following chemotherapy, irradiation and marrow transplantation for an identical twin. N Engl J Med 1979; 300: 33-337.
2. Clift RA, Buckner CD, Thomas ED et al. Treatment of chronic granuloytic leukaemia in chronic phase by allogeneic marrow transplantation. Lancet 1982; ii: 621-623.
3. Goldman JM, Baughan AS, McCarthy DM et al. Marrow transplantation for patients in the chronic phase of chronic granuloytic leukaemia. Lancet 1982; ii: 623-625.
4. Speck B, Gratwohl A, Nissen C et al. Allogeneic marrow transplantation for chronic granulocytic leukemia. Blut 1982; 45: 237-242.
5. Speck B, Bortin MM, Champlin R et al. Allogeneic bone marrow transplantation for chronic myeloid leukemia. Lancet 1984; i: 665-668.
6. Gratwohl A, Hermans J, Baldomero H. Hematopoietic precursor cell transplants in Europe: activity in 1994. Bone Marrow Transplant 1996, 17: 137-148.
7. Gratwohl A, Hermans J, Niederwieser D et al. for the Chronic Leukemia Working Party of the European Group for Bone Marrow Transplantation. Bone marrow transplantation for chronic myelogenous leukemia: long-term effects. Bone Marrow Transplant 1993; 12: 509.
8. Gratwohl A, Hermans J, v. Biezen A et al. No advantage for patients who receive splenic irradiation before bone marrow transplantation for chronic myeloid leukemia: results of a prospective randomized study. Bone Marrow Transplant 1992; 10: 147.
9. Gratwohl A, Hermans J, Apperley J et al. for the Working Party Chronic Leukemia of the European Group for Blood and Marrow Transplantation (EBMT). Acute graftversus-host disease: grade and outcome in patients with chronic myelogeneous leukemia. Blood 1995; 86: 813.
10. Devergie A, Carreras E, Prentice G, Labopin M, Apperley J. Outcome of unrelated bone marrow transplantation for chronic myeloid leukemia. Bone Marrow Transplant 1995; 52: (Suppl. 2) (abstract).
11. van Rhee F, Szydlo RM ,Hermans J et al. for the Chronic Leukemia Working Party of the European Group for Blood and Marrow Transplantation. Long-term results after allogeneic bone marrow transplantation for chronic myelogenous leukemia (in press 1966).
12. Clift R, Goldman J, Gratwohl A, Horowitz MM. Proposals for standardized reporting of results of bone marrow transplantation for leukaemia. Bone Marrow Transplant 1989; 4: 445-448.
13. Clift RA, Appelbaum FR, Thomas ED. Treatment of chronic myeloid leukemia by marrow transplantation. Blood 1992; 82: 1954-1956.
14. Armitage JO: Bone marrow transplantation. N Engl J Med 1994; 330: 828.